Strategy

Strengthening the Medical-Commercial Partnership with Top 10 Global Pharmaceutical Company

Strengthening the Medical-Commercial Partnership with Top 10 Global Pharmaceutical Company

Join Talitha Lynch, VP of global medical affairs operations at a top 10 global pharmaceutical company, and Robert Groebel, VP, Global Medical Strategy, Veeva, as they discuss how to foster meaningful collaboration and strategic information sharing across the organization.

McCann Health forms new global consultancy

McCann Health forms new global consultancy

By

The consultancy includes Double Helix, which was acquired by McCann in 2012.

The Future is Here - 6 Ways To Skyrocket Your Website Results

The Future is Here - 6 Ways To Skyrocket Your Website Results

Learn six ways to apply this data to new types of highly efficient and effective digital strategies.

Digitas Health LifeBrands' Susan Manber on telling a healthy story

Digitas Health LifeBrands' Susan Manber on telling a healthy story

By

The chief planning officer of North America talks about strategy and how to tell an engaging health story.

5 Keys to Success in the New Patient Economy

5 Keys to Success in the New Patient Economy

In the webinar, 5 Keys to Success in the New Patient Economy, you'll learn tips and strategies for transforming your patient engagement model.

Sales Enablement for MedTech: A Better Way to Engage HCPs

Sales Enablement for MedTech: A Better Way to Engage HCPs

Join this webcast to see how a solid sales enablement strategy that is combined with the right technology can help your sales teams engage with providers more effectively.

Catch Us If You Can: The Email Channel Has Taken Off While You've Been Left Behind

Catch Us If You Can: The Email Channel Has Taken Off While You've Been Left Behind

This message will be clear: catch up to the email channel. Now.

Sandoz: Zarxio marketing to be similar to a branded-drug launch

Sandoz: Zarxio marketing to be similar to a branded-drug launch

By

Sandoz plans to take a branded approach as it launches the first FDA-approved biosimilar product.

Sunovion prepares for FDA decision on Aptiom

Sunovion prepares for FDA decision on Aptiom

By

The FDA is expected to announce this week whether it has approved the epilepsy drug as a monotherapy for partial-onset seizures.

OPINION

Email Newsletters